SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 43 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $97,297,084 | +1.6% | 96,994,000 | 0.0% | 1.93% | -15.2% |
| Q4 2022 | $95,739,137 | +0.5% | 96,994,000 | 0.0% | 2.28% | +4.5% |
| Q3 2022 | $95,234,000 | +0.8% | 96,994,000 | 0.0% | 2.18% | +2.6% |
| Q2 2022 | $94,477,000 | -0.1% | 96,994,000 | +1.4% | 2.13% | +15.4% |
| Q1 2022 | $94,537,000 | +28.3% | 95,694,000 | +29.3% | 1.84% | +19.8% |
| Q4 2021 | $73,675,000 | +93.5% | 74,027,000 | +92.6% | 1.54% | +76.1% |
| Q3 2021 | $38,079,000 | +65.3% | 38,428,000 | +64.7% | 0.87% | +74.8% |
| Q2 2021 | $23,040,000 | – | 23,328,000 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|